| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8629940 | Diabetes Research and Clinical Practice | 2018 | 8 Pages |
Abstract
FRDADm can be controlled by individualized treatment regimen with insulin or oral antidiabetics. Patients with DM in FRDA may show a relevant risk to ketoacidotic complications, which should be avoided.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Angeliki Pappa, Martin G. Häusler, Andreas Veigel, Konstantina Tzamouranis, Martin W. Pfeifer, Andreas Schmidt, Martin Bökamp, Holger Haberland, Siegfried Wagner, Joachim Brückel, Gideon de Sousa, Lukas Hackl, Esther Bollow, Reinhard W. Holl,